Form 8-K - Current report:
SEC Accession No. 0001479290-17-000032
Filing Date
2017-08-02
Accepted
2017-08-02 17:04:55
Documents
3
Period of Report
2017-07-28
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rvnc8-2x178xk.htm 8-K 32901
2 EXHIBIT 99.1 rvnc8-2x17exhibit991.htm EX-99.1 12983
3 GRAPHIC rvncnewlogoa11.jpg GRAPHIC 26009
  Complete submission text file 0001479290-17-000032.txt   82905
Mailing Address 7555 GATEWAY BLVD. NEWARK CA 94560
Business Address 7555 GATEWAY BLVD. NEWARK CA 94560 510-742-3400
Revance Therapeutics, Inc. (Filer) CIK: 0001479290 (see all company filings)

IRS No.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36297 | Film No.: 171001065
SIC: 2834 Pharmaceutical Preparations